Mettler-Toledo Change in Accounts Payable 2010-2025 | MTD
Mettler-Toledo annual/quarterly change in accounts payable history and growth rate from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
- Mettler-Toledo change in accounts payable for the quarter ending June 30, 2025 was $-0.009B, a 78.42% increase year-over-year.
- Mettler-Toledo change in accounts payable for the twelve months ending June 30, 2025 was $-0.021B, a 84.45% decline year-over-year.
- Mettler-Toledo annual change in accounts payable for 2024 was $0.012B, a 129.79% decline from 2023.
- Mettler-Toledo annual change in accounts payable for 2023 was $-0.041B, a 193.32% increase from 2022.
- Mettler-Toledo annual change in accounts payable for 2022 was $-0.014B, a 114.71% decline from 2021.
| Mettler-Toledo Annual Change in Accounts Payable (Millions of US $) |
|
|---|---|
| 2024 | $12 |
| 2023 | $-41 |
| 2022 | $-14 |
| 2021 | $94 |
| 2020 | $-18 |
| 2019 | $-12 |
| 2018 | $34 |
| 2017 | $12 |
| 2016 | $10 |
| 2015 | $2 |
| 2014 | $6 |
| 2013 | $0 |
| 2012 | $-28 |
| 2011 | $28 |
| 2010 | $32 |
| 2009 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $26.465B | $3.872B |
| Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The company focuses on the high value-added segments of the weighing instruments market by providing solutions for specific applications. Mettler-Toledo is also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. The company has three reportable segments: Laboratory Instruments, Industrial Instruments and Retail Weighing Solutions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.456B | 22.32 |
| Intuitive Surgical (ISRG) | United States | $170.011B | 70.47 |
| IDEXX Laboratories (IDXX) | United States | $51.341B | 53.43 |
| Edwards Lifesciences (EW) | United States | $47.714B | 31.62 |
| Alcon (ALC) | Switzerland | $40.175B | 26.97 |
| IQVIA Holdings (IQV) | United States | $31.919B | 18.04 |
| DexCom (DXCM) | United States | $29.851B | 44.78 |
| STERIS (STE) | Ireland | $24.483B | 26.06 |
| Waters (WAT) | United States | $17.627B | 24.21 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.949B | 0.00 |
| Hologic (HOLX) | United States | $14.820B | 16.06 |
| Penumbra (PEN) | United States | $10.374B | 75.78 |
| Globus Medical (GMED) | United States | $8.357B | 19.28 |
| Sysmex ADR (SSMXY) | Japan | $8.133B | 25.84 |
| Masimo (MASI) | United States | $7.782B | 26.19 |
| Teleflex (TFX) | United States | $5.623B | 9.08 |
| Glaukos (GKOS) | United States | $5.379B | 0.00 |
| TransMedics (TMDX) | United States | $3.927B | 59.68 |
| Integer Holdings (ITGR) | United States | $3.800B | 18.96 |
| LivaNova (LIVN) | United Kingdom | $3.090B | 17.68 |
| Alphatec Holdings (ATEC) | United States | $2.375B | 0.00 |
| Veracyte (VCYT) | United States | $2.287B | 31.60 |
| PROCEPT BioRobotics (PRCT) | United States | $2.254B | 0.00 |
| Artivion (AORT) | United States | $2.078B | 104.83 |
| Nihon Kohden (NHNKY) | Japan | $1.950B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $1.864B | 17.43 |
| Integra LifeSciences Holdings (IART) | United States | $1.150B | 6.59 |
| Pulse Biosciences (PLSE) | United States | $1.138B | 0.00 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| IRadimed (IRMD) | United States | $0.925B | 44.87 |
| Tandem Diabetes Care (TNDM) | United States | $0.827B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.537B | 9.49 |
| Treace Medical Concepts (TMCI) | United States | $0.470B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 3.66 |
| AngioDynamics (ANGO) | United States | $0.398B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.396B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.70 |
| RxSight (RXST) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.290B | 20.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.282B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| 908 Devices (MASS) | United States | $0.228B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.177B | 0.00 |
| Accuray (ARAY) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.136B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| InspireMD (NSPR) | United States | $0.103B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.091B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.48 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |